1. Singapore Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Haw Par Corporation Limited

Haw Par Corporation Limited

HAWPF
Haw Par Corporation LimitedUS flagOther OTC
12.00
USD
- -
- -
2.66BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.65
0.7
0.82
0.92
1.01
1.08
1.1
0.5
0.64
0.82
1.05
1.11
- -
1.1
Basic EPS, GAAP
0.49
0.54
0.84
0.57
0.56
0.81
0.82
0.54
0.5
0.67
0.98
1.03
- -
0.82
Free Cash Flow per Basic Share
0.42
0.25
0.56
0.4
0.28
0.3
0.37
0.08
0.07
0.1
0.25
0.23
- -
0.37
Dividend per Share
0.19
0.2
0.2
0.39
0.2
0.25
1.15
0.3
0.3
0.3
0.35
0.4
- -
1.15
Book Value per Share
4.85
5.19
5.84
5.28
5.75
6.52
6.21
6.52
6.72
7.09
7.72
8.35
- -
6.22
Tangible Book Value per Share
11.14
12.78
11.52
10.55
13.95
13.22
14.23
13
14.46
15.98
15.65
18.69
- -
14.23
Basic Weighted Avg Shares
219
219
219
219
220
221
221
221
221
221
221
221
- -
221
Sales/Revenue/Turnover
141
154
179
202
223
238
244
111
141
182
232
245
230
244
Operating Margin (%)
26.49
27.87
29.79
35.75
32.18
35.01
32.35
12.55
17.49
23.82
27.58
26.08
29.17
32.35
Depreciation Expense
5
5
5
3
6
6
6
7
6
6
6
6
6
6
Net Income, GAAP
108
119
183
125
122
179
182
120
110
148
217
228
265
182
Effective Tax Rate (%)
6.38
6.41
5.36
9.95
11.16
6.87
7.49
3.57
5.23
6.7
5.59
7.25
5.75
7.49
Profit Margin (%)
76.44
77.05
102.48
62.01
54.97
75.3
74.68
107.87
77.99
81.45
93.32
93.24
115.43
74.68
Working Capital
572
621
631
2,276
3,046
2,826
3,063
2,775
3,100
3,153
3,190
3,915
4,165
3,063
LT Debt
- -
- -
- -
46
45
- -
9
1
1
29
28
- -
45
9
Total Equity
2,445
2,807
2,535
2,325
3,078
2,928
3,156
2,885
3,211
3,549
3,476
4,149
4,291
3,156
Return on Invested Capital (%)
1.47
1.5
1.85
2.59
2.27
2.52
2.37
0.44
0.77
1.19
1.7
1.54
1.47
2.37
Return on Capital (%)
10.33
10.48
14.6
9.74
9.43
12.73
12.78
8.46
7.51
9.64
13.07
12.72
14.13
12.78
Return on Common Equity (%)
10.54
10.83
15.17
10.26
10.11
13.24
12.95
8.51
7.52
9.7
13.21
12.84
14.54
12.95

Capital Structure

FRC

•

in mil. unless spec.
Jun'19
Sep'19
Dec'19
ST Debt
24
24
9
LT Borrowings
24
24
8
LT Finance Leases
- -
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
221
221
221
Market Capitalization
2,596
2,517
2,413

Working Capital

FRC

•

in mil. unless spec.
Jun'19
Sep'19
Dec'19
Total Current Assets
3,045
3,030
3,138
Cash, Cash Equivalents & STI
2,975
2,969
3,087
Accounts Receivable, Net
49
41
24
Inventories
22
19
20
Total Current Liabilities
102
102
75
Payables & Accruals
- -
- -
- -
ST Debt
24
24
9
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.1%
8.51%
3.44%
Free Cash Flow
8.3%
37.85%
9.3%
Net Income, GAAP
7.42%
18.87%
16.29%
Sales/Revenue/Turnover
6.11%
16.6%
-6.07%
Total Cash Common Dividend
63.98%
56.21%
250%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
232
2024
- -
- -
- -
- -
245
2025
- -
- -
- -
- -
230

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.98
2024
- -
- -
- -
- -
1.03
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.35
2024
- -
- -
- -
- -
0.4
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Ee Lim Wee
Full Time Employees
595
Sector
Healthcare
Industry
Drug Manufacturers - General
Address
No. 03-03 Haw Par Technocentre Singapore Singapore 149598
IPO Date
Mar 5, 1996
Website
hawpar.com
Similar Companies
Grifols, S.A. (GIFOF)
Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
Merck & Co., Inc. (6MK.DE)
Orion Oyj (ORINF)
Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)
Sanofi (SNYNF)
Business
Haw Par Corporation Limited, a Singapore-based multinational investment holding company listed on the Singapore Exchange since 1969 and headquartered at 401 Commonwealth Avenue, Singapore 129595, manufactures, markets and distributes healthcare products including topical analgesics under the Tiger Balm brand such as Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch and Tiger Balm Oil, and under the Kwan Loong brand such as Kwan Loong Medicated Oil and Kwan Loong Refresher; it engages in long-term investments primarily in quoted securities in Asia with major holdings in United Overseas Bank Limited and UOL Group Limited; owns and leases investment properties in prime locations in Singapore and Malaysia; and provides family and tourist-oriented leisure activities through oceanariums. The company operates its healthcare segment in over 100 countries across the Association of Southeast Asian Nations, other Asian countries and internationally, with its leisure and property businesses focused in Asia. In recent developments, Tiger Balm signed a four-year regional partnership with FC Bayern Munich covering Singapore, Thailand, Malaysia, Vietnam, Hong Kong SAR and other markets; the company opened a new manufacturing facility in Johor, Malaysia, which commenced commercial production in September 2024 to support production capacity expansion; and it declared a special dividend of S$1.00 per share in 2024 alongside a regular dividend, reflecting strong financial performance with group turnover rising to S$244.8 million and profit from operations increasing to S$241.9 million for the year ended December 31, 2024.